Cargando…
P2X7Rs: new therapeutic targets for osteoporosis
Increasing evidence suggests that both the occurrence and progression of osteoporosis are associated with inflammation, especially in primary osteoporosis. The maintenance of skeletal homeostasis is dependent on the complex regulation of bone metabolism. Numerous evidence suggested that purinoceptor...
Autores principales: | Huang, Haoyun, He, Yu-Mei, Lin, Miao-Miao, Wang, Yanchao, Zhang, Xiaomei, Liang, Li, He, Xueling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984661/ https://www.ncbi.nlm.nih.gov/pubmed/35106736 http://dx.doi.org/10.1007/s11302-021-09836-0 |
Ejemplares similares
-
Senescent cells: A therapeutic target for osteoporosis
por: Wang, Tiantian, et al.
Publicado: (2022) -
P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
por: Cisneros-Mejorado, Abraham J., et al.
Publicado: (2020) -
Editorial: P2X7 as Common Therapeutic Target in Brain Diseases
por: Engel, Tobias, et al.
Publicado: (2021) -
Lack of Association between Missense Variants in GRHL3 (rs2486668 and rs545809) and Susceptibility to Non-Syndromic Orofacial Clefts in a Han Chinese Population
por: He, Miao, et al.
Publicado: (2016) -
Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression
por: Li, Huiming, et al.
Publicado: (2019)